124 related articles for article (PubMed ID: 32946958)
1. Albumin fusion at the N-terminus or C-terminus of human lactoferrin leads to improved pharmacokinetics and anti-proliferative effects on cancer cell lines.
Ueda K; Shimizu M; Ohashi A; Murata D; Suzuki T; Kobayashi N; Baba J; Takeuchi T; Shiga Y; Nakamura M; Kagaya S; Sato A
Eur J Pharm Sci; 2020 Dec; 155():105551. PubMed ID: 32946958
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life.
Shiga Y; Oshima Y; Kojima Y; Sugimoto A; Tamaki N; Murata D; Takeuchi T; Sato A
Eur J Pharm Sci; 2015 Jan; 67():136-143. PubMed ID: 25433245
[TBL] [Abstract][Full Text] [Related]
3. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
4. Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration.
Nopia H; Kurimoto D; Sato A
Biometals; 2023 Jun; 36(3):629-638. PubMed ID: 36167912
[TBL] [Abstract][Full Text] [Related]
5. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment.
Kurimoto D; Sato A
Eur J Pharm Sci; 2023 Dec; 191():106591. PubMed ID: 37742986
[TBL] [Abstract][Full Text] [Related]
6. Intracellularly delivered human lactoferrin functions as an activator of Na
Kurimoto D; Hue Anh TD; Kasama R; Sato A
Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
[TBL] [Abstract][Full Text] [Related]
7. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
[TBL] [Abstract][Full Text] [Related]
8. Expression and bioactivity of recombinant human serum albumin and dTMP fusion proteins in CHO cells.
Ru Y; Zhi D; Guo D; Wang Y; Li Y; Wang M; Wei S; Wang H; Wang N; Che J; Li H
Appl Microbiol Biotechnol; 2016 Sep; 100(17):7565-75. PubMed ID: 27115755
[TBL] [Abstract][Full Text] [Related]
9. Albumin Fusion at the N-Terminus or C-Terminus of HM-3 Leads to Improved Pharmacokinetics and Bioactivities.
Li T; Zhang HZ; Ge GF; Yue ZR; Wang RY; Zhang Q; Gu Y; Song MJ; Li WB; Ma MZ; Wang MZ; Yang H; Li Y; Li HY
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572270
[TBL] [Abstract][Full Text] [Related]
10. Efficient expression of stable recombinant human insulin-like growth factor-1 fusion with human serum albumin in Chinese hamster ovary cells.
Wan A; Xu D; Liu K; Peng L; Cai Y; Chen Y; He Y; Yang J; Jin J; Li H
Prep Biochem Biotechnol; 2017 Aug; 47(7):678-686. PubMed ID: 28281882
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities.
Lönnerdal B; Jiang R; Du X
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):606-14. PubMed ID: 21832946
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Proliferative Effect of Human Lactoferrin and Its Proteolytic Peptide on Normal and Transformed Epithelial Cells.
Hwang SM; Chung IY; Jo JH; Yoon TJ; Lee HH
Appl Biochem Biotechnol; 2016 Jan; 178(1):44-57. PubMed ID: 26400493
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin, a Critical Player in Neonate Intestinal Development: RHLF may be a Good Choice in Formula.
Wang W; Cheng Z; Wang X; An Q; Huang K; Dai Y; Meng Q; Zhang Y
J Agric Food Chem; 2021 Aug; 69(31):8726-8736. PubMed ID: 34323077
[TBL] [Abstract][Full Text] [Related]
14. Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β.
Ji SI; Park JH; You HG; Chi HJ; Bang YW; Cha SH
Immunol Lett; 2019 Mar; 207():46-55. PubMed ID: 30684504
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of a Silk Sericin Hydrogel System Delivering Human Lactoferrin Using Genetically Engineered Silk with Improved Bioavailability to Alleviate Chemotherapy-Induced Immunosuppression.
Xu S; Tan H; Yang Q; Wang R; Tian C; Ji Y; Zhao P; Xia Q; Wang F
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45175-45190. PubMed ID: 34525798
[TBL] [Abstract][Full Text] [Related]
16. Efficient Endocytosis of the Human Lactoferrin N-Lobe Enhances Its Antiproliferative Activity against Human Cancer Cells.
Nakamura M; Shiga A; Iimori A; Matsuzaki T
Biol Pharm Bull; 2023 Jul; 46(7):1004-1009. PubMed ID: 37088555
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human lactoferrin and iron transport across Caco-2 monolayers: effect of heat treatment on the binding to cells.
Conesa C; Pocoví C; Pérez MD; Calvo M; Sánchez L
J Agric Food Chem; 2008 Apr; 56(8):2831-7. PubMed ID: 18355020
[TBL] [Abstract][Full Text] [Related]
18. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.
van Berkel PH; Geerts ME; van Veen HA; Kooiman PM; Pieper FR; de Boer HA; Nuijens JH
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):107-14. PubMed ID: 7492299
[TBL] [Abstract][Full Text] [Related]
19. Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells.
Wan A; Miao Y; Peng L; Cai Y; Chen Y; He Y; Yang J; Jin J; Li H
Bioengineered; 2017 Sep; 8(5):600-612. PubMed ID: 28281868
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
